Pathway Bioventures
Pathway Bioventures is a Pre-Seed, Seed venture capital firm based in Cambridge, MA investing in Healthcare, Other. The firm typically writes $250K–$3.0M checks and has 16 portfolio companies in our records.
Pre-Seed, Seed
$250K – $3.0M
16+ companies
5 partners
Investment Thesis
Dedicated to early-stage biotech with cutting-edge innovations in oncology and cell therapy solutions, focusing on niche applications.
How Pathway Bioventures invests
Pathway Bioventures is a vc firm based in Cambridge, MA. The firm invests at the Pre-Seed, Seed stages, with a focus on Healthcare, Other. It does not invest in Consumer, Media.
Pathway Bioventures typically writes checks of $250K–$3.0M per investment.
Pathway Bioventures has backed 16 companies in our records, including BioRegen Therapeutics, TumorTarget Biotech, AIRNA Therapeutics.
Meet the Team
Emily Nguyen
Founding GP
Industry Focus
Invests In
Does Not Invest In
Portfolio Companies (16)
Other
BioRegen Therapeutics
TumorTarget Biotech
AIRNA Therapeutics
Pioneering the discovery and development of RNA editing therapeutics for patients with rare and common diseases.
AXONIS Therapeutics
Advancing breakthroughs in neuroscience to develop first-in-class precision therapies for neurological disorders.
BioGraph55
Developing bispecific antibodies against a novel subset of immunosuppressive cells to treat resistant cancers.
IpiNovyx Bio
Develops next-generation, ultra-selective proteasome inhibitors for oncology and autoimmune disease applications.
miRecule
Developing RNA-based therapeutics for cancer and muscular dystrophy.
Modifi Bio
Creating a new class of oral medicines that selectively kill cancer cells via direct DNA modification.
Nionyx Bio
Developing transformative gene therapies for patients with severe kidney diseases.
Ochre Bio
Developing novel RNA-based therapeutics for chronic liver diseases.
- •Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, Other — the sectors they actively back.
- •Size your ask to their typical $250K – $3.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Daniel Jacobs, Managing Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Pathway Bioventures is a match for your startup
Upload your pitch deck to see how well you match with Pathway Bioventures and 10,000+ other investors.
Is this your profile? Request a correction or removal